1. Development of abbreviated new drug applications during the COVID-19 pandemic: questions and answers Publication: [Silver Spring, MD] : Center for Drug Evaluation and Research, September 8, 2021 Subject(s): COVID-19Drug ApprovalUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration